English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Diabetes Mellitus (DM) is a risk factor for periodontitis, at the same time, the metabolic control of diabetic patients gets more difficult due to the presence of periodontal infection, increasing the risk of chronic complications and possibly, death by diabetes. It is recognized that both diseases are related because the inflammation factors generated by the periodontitis as well as the oral cavity bacteria in the systemic circulation, may act as aggravating factor for insulin resistance and worsen the glycemic control. It is clear that an opportune treatment of PD would improve the quality of life and the metabolic control of diabetic patients. The objectives of the current paper are to evaluate the impact of the periodontal therapy in both clinical and metabolic parameters in type 2 diabetic and prediabetic obese patients and to demonstrate that uncontrolled diabetics can be treated successfully, without increasing their medical risk. Nine DM2 and 7 glucose intolerant obese patients were selected. All of them suffering severe chronic periodontitis. All patients were treated following a protocol designed by us and medical indications were not modified. The DM2 patients showed approximately a 1% decrease in HbAlc after 6 months of the periodontal treatment. No complication was observed and no patient needed major medical assistance. The response to the periodontal treatment was similar in both groups, with a significant improvement in clinical parameters. Although the decrease in HbA1C was not statistically significant, our results are very promising at the clinical setting. Rev. Clin. Periodoncia Implantol. Rehabil. Oral Vol. 4(2); 50-53, 2011.

Respuesta al tratamiento periodontal de diabéticos tipo 2 con mal control metabólico y obesos intolerantes a la glucosa, con periodontitis severa